Patents by Inventor Richard N. Pierson

Richard N. Pierson has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Use of Recombinant Human Activated Protein C to Enhance Viability of Transplant Tissue
    Publication number: 20180146660
    Abstract: The present invention relates to the use of activated Protein C (aPC) to enhance the viability of transplant graft. In certain instances, the invention provides methods of ex vivo perfusion of transplant graft with a composition comprising aPC.
    Type: Application
    Filed: June 3, 2016
    Publication date: May 31, 2018
    Inventors: Donald G. Harris, Agnes M. Azimzadeh, Richard N. Pierson III
  • Method for inhibiting complement activation
    Publication number: 20030144358
    Abstract: A method of inhibiting complement activation, particularly by a transplanted tissue, in a warm-blooded vertebrate. The method includes administering a therapeutically effective amount of a platelet activity modulator to a warm-blooded vertebrate before, during or after a tissue is transplanted to the warm-blooded vertebrate, whereby complement activation by the transplanted tissue is inhibited. The platelet activity modulator can include a combination of a GPIb modulator and a GPIIb/GPIIIa modulator.
    Type: Application
    Filed: December 2, 2002
    Publication date: July 31, 2003
    Inventors: Richard N. Pierson, George L. Zorn, Todd D. Giorgio, Simon Robson, Agnes M. Azimzadeh
  • Method for inhibiting complement activation
    Patent number: 6538028
    Abstract: A method of inhibiting complement activation, particularly by a transplanted tissue, in a warm-blooded vertebrate. The method includes administering a therapeutically effective amount of a platelet activity modulator to a warm-blooded vertebrate before, during or after a tissue is transplanted to the warm-blooded vertebrate, whereby complement activation by the transplanted tissue is inhibited. The platelet activity modulator can include a combination of a GPIb modulator and a GPIIb/GPIIIa modulator.
    Type: Grant
    Filed: February 1, 2001
    Date of Patent: March 25, 2003
    Assignees: Vanderbilt University, Beth Israel Deaconess Medical Center
    Inventors: Richard N. Pierson, III, George L. Zorn, III, Todd D. Giorgio, Simon Robson, Agnes M. Azimzadeh
  • Method of predicting body composition in prepubertal children infected with human immunodenficiency virus
    Patent number: 5840042
    Abstract: A method for predicting fat free mass (FFM) and total body water (TBW) of a prepubertal child infected with human immunodeficiency virus (HIV) comprises the steps of measuring a child's height, measuring the child's total body resistance, and predicting fat free mass (FFM) and total body weight (TBW) of said child using the measured height and total body resistance.
    Type: Grant
    Filed: May 16, 1997
    Date of Patent: November 24, 1998
    Assignee: St. Luke's-Roosevelt Hospital
    Inventors: Stephen M. Arpadi, Mary Horlick, Donald P. Kotler, Richard N. Pierson, John Thornton, Jack Wang